SHPMY:OTCMKTS
Shanghai Pharmaceuticals Holdings ADR
$7.08
0.00%
(0.00) 1D
Oct 1, 2:50:24 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SHPMY...
Mkt. cap
63.48B
Avg. vol.
125.00
Volume
61.00
52-wk high
$8.23
52-wk low
$6.41
Beta
0.58
Shares outstanding
183.81M
No. of employees
49K
Mkt. cap
63.48B
Avg. vol.
125.00
Volume
61.00
52-wk high
$8.23
52-wk low
$6.41
Beta
0.58
Shares outstanding
183.81M
No. of employees
49K
News stories
From web sources and news partners
EQS News
·
26 minutes ago
Solidion Technology (NASDAQ: STI) Sees no Basis to Increase Its Offer to Polar Power, Inc. (NASDAQ: POLA) in Response to Board Rejection of All-Cash Asset Acquisition Proposal | Corporate
Simply Wall Street
·
1 hour ago
Will Mood And Mind Drinks Change Walmart's (WMT) Narrative
Axios
·
1 hour ago
Wall Street is on track for record profits
Yahoo Finance
·
59 minutes ago
3 S&P 500 Stocks to Consider Right Now
Profile
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
About Shanghai Pharmaceuticals Holdings ADR